urea/hemorrhage

FIELD OF THE INVENTION The present invention relates to the use of sulfonyl semicarbazides, semicarbazides and ureas, as well as derivatives and analogs thereof, and pharmaceutical compositions containing the same, for the treatment or prophylaxis of viral infections and diseases associated

FIELD OF THE INVENTION The present invention relates to the use of sulfonyl semicarbazides, semicarbazides and ureas, as well as derivatives and analogs thereof, and pharmaceutical compositions containing the same, for the treatment or prophylaxis of viral infections and diseases associated

SEQUENCE LISTING The instant application contains a Sequence Listing which has been submitted in ASCII format via EFS-Web and is hereby incorporated by reference in its entirety. Said ASCII copy, created on Jan. 21, 2011, is named 56441024.txt and is 9,154 bytes in size. FIELD The use of sulfonyl

SEQUENCE LISTING The instant application contains a Sequence Listing which has been submitted in ASCII format via EFS-Web and is hereby incorporated by reference in its entirety. Said ASCII copy, created on Feb. 9, 2011, is named 5644102.txt and is 9,265 bytes in size. FIELD OF THE INVENTION The

SEQUENCE LISTING The instant application contains a Sequence Listing which has been submitted in ASCII format via EFS-Web and is hereby incorporated by reference in its entirety. Said ASCII copy, created on Oct. 12, 2011, is named 56441026.txt and is 7,802 bytes in size. FIELD The use of sulfonyl

FIELD OF THE INVENTION The present invention relates to the use of sulfonyl semicarbazides, semicarbazides and ureas, as well as derivatives and analogs thereof, and pharmaceutical compositions containing the same, for the treatment or prophylaxis of viral infections and diseases associated

FIELD The use of sulfonyl semicarbazides, carbonyl semicarbazides semicarbazides, and ureas, as well as derivatives and analogs thereof, and pharmaceutical compositions containing the same, for the treatment or prophylaxis of viral infections and diseases associated therewith. In particular, those

BACKGROUND OF THE INVENTION 1. Field of the Invention The invention is concerned with the production of endogenous prostaglandins by mammals and, more specifically, concerns a method of raising prostaglandin production levels in the mammal by administering 1-pyridylalkyl-3-naphthyl-2(thio)ureas. The

BACKGROUND OF THE INVENTION 1. Field of the Invention This invention relates to aesthetically pleasing multicolored dentifrices and more particularly to a striped toothpaste or gel wherein there is virtually no colorant bleeding between the multicolored sections. 2. The Prior Art Aesthetic effects

FIELD OF THE INVENTION This invention is directed to a method and composition useful for the preventative and curative treatment of exercise induced pulmonary hemorrhage in animals. More particularly, this invention relates to the health management of animal populations and to a method and

BACKGROUND OF THE INVENTION 1. Field of the Invention The invention is concerned with the production of endogenous prostaglandins by mammals and more specifically concerns a method of raising prostaglandin production levels in the mammal by administering 1-pyridylalkyl-3-phenylureas. The invention

BACKGROUND OF THE INVENTION 1. Field of the Invention The invention is concerned with the production of endogenous prostaglandins by mammals and more specifically concerns a method of raising prostaglandin production levels in the mammal by administering 1-pyridylalkyl-3-phenylureas. The invention

FIELD OF THE INVENTION The present invention concerns novel urea and thiourea derivatives of substituted quinoxaline 2,3-diones having utility as glutamate receptor antagonists. The fused ring quinoxaline 2,3-dione system is substituted at the a- or b-position by urea or thiourea derivatives. The

TECHNICAL FIELD The present invention relates to a method for producing an isoquinoline derivative or a salt thereof which is useful for preventing and treating cerebrovascular disorders such as cerebral infarction, cerebral hemorrhage, subarachnoid hemorrhage, and cerebral edema, particularly as a

This application is a National Stage of PCT/JP11/069,187 filed Aug. 25, 2011 and claims the benefit of JP 2010-189392 filed Aug. 26, 2010. TECHNICAL FIELD The present invention relates to a method for producing an isoquinoline derivative or a salt thereof which is useful for preventing and treating